A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pralsetinib-13C3-15N2 - Request Quote

Picture of Pralsetinib-13C3-15N2

Pralsetinib-13C3-15N2

SZ CAT No:SZ-P164D01
CAS No
NA
Mol.F.
C2413C3H32FN715N2O2
Mol.Wt.
538.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Pralsetinib-13C3-15N2 is chemically (1s,4R)-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-(methyl-13C)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl-2,5-13C2-1,3-15N2)cyclohexane-1-carboxamide. Pralsetinib-13C3-15N2 is supplied with detailed characterization data compliant with regulatory guideline. Pralsetinib-13C3-15N2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pralsetinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Pralsetinib-13C3-15N2

Purchase Pralsetinib-13C3-15N2

Pralsetinib-13C3-15N2 suppliers

Pralsetinib-13C3-15N2 manufacturers

Pralsetinib-13C3-15N2 price

Order Pralsetinib-13C3-15N2

Enquire Pralsetinib-13C3-15N2

Pralsetinib-13C3-15N2 cost

Pralsetinib-13C3-15N2 Supplier

Pralsetinib-13C3-15N2 Distributor

Pralsetinib-13C3-15N2 for Method Validation

Pralsetinib Reference Standard

Pralsetinib-13C3-15N2 for ANDA Filing

Pralsetinib-13C3-15N2 for Forced Degradation Studies

Pralsetinib-13C3-15N2 Identification Standards

Pralsetinib-13C3-15N2 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,